Clinical observation of ultrasound-guided stellate ganglion block combined with acupuncture in the treatment of fibromyalgia syndrome

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ITMCTR

Registry ID

ITMCTR2100005374

Enrollment

Unknown

Registered

2021-12-04

Start date

2021-12-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia syndrome

Interventions

Acupuncture group:Give acupuncture treatment

Ultrasound guided stellate ganglion block combined with acupuncture treatment group:The patients were treated with stellate ganglion block combined with acupuncture under the guidance of ultrasound

Ultrasound guided stellate ganglion block group:The patients were treated with stellate ganglion block under ultrasound guidance

Eligibility

Sex/Gender

Male

Age

16 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of the disease; 2. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Secondary fibromyalgia syndrome, such as osteoarthritis, rheumatoid arthritis, osteoporosis and other rheumatic diseases; 2. Suffering from malignant tumor, chronic infection, epilepsy, coagulation dysfunction, cognitive and mental abnormalities, or serious heart disease, abnormal liver and kidney function; 3. People who are allergic to local anesthetics and those who have fainted; 4. Pregnant and lactating; 5. The elderly and children over 80 years old; 6. Incomplete information.

Design outcomes

Primary

Measure	Time frame
Morning stiffness duration;PSQI;VAS;Heart rate variability monitoring;Infrared thermal imaging;HAMD;Location and quantity of pain;FIQR;	—

Countries

China

Contacts

Public ContactShu ya

shuyazhitong@sina.com18629362078

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026